ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
약시 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 CAGR 4.3%로 57억 6,000만 달러로 성장합니다. 예측 기간 중 성장 요인으로는 디지털 건강 플랫폼의 부상, 부모를 위한 리소스 및 지원 증가, 어린이 예방 의료의 중요성, 약시에 대한 인식 증가, 안과 전문센터 및 클리닉의 급증 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 진단 기술 발전, 새로운 치료법 개발, 시각 발달에 대한 이해의 발전, 신경가소성 발견, 신약 개발 및 승인 등이 있습니다.
향후 5년간 4.3%의 성장률 전망은 지난번 예측보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 중국에서 조달하는 소아 시력 치료 기기 및 교합 패치의 비용을 상승시켜 미국 시장을 저해하고, 치료 효과를 떨어뜨리며, 소아 안과 지출을 증가시킬 것으로 예측됩니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
안과 질환의 유병률 증가는 향후 약시 시장의 성장을 가속할 것으로 예측됩니다. 안과 질환에는 백내장, 녹내장과 같은 흔한 질환부터 망막색소변성증, 안구 종양과 같은 희귀질환까지 눈에 영향을 미치는 다양한 질환이 포함됩니다. 이러한 질환 증가 요인으로는 스크린 사용 시간 증가, 인구의 고령화, 오염 등의 환경적 요인을 들 수 있습니다. 특히 약시는 뇌가 약한 쪽 눈의 입력을 무시함으로써 안과 질환을 악화시킬 수 있으며, 방치할 경우 영구적인 시력 장애나 깊이 지각 문제로 이어질 수 있습니다. 미국 질병예방통제센터(CDC)에 따르면 2024년 1월 기준 40세 이상 미국인 중 340만 명 이상이 실명 또는 시각 장애를 앓고 있으며, 이 수치는 2030년까지 두 배로 늘어날 것으로 예측됩니다. 따라서 안과 질환의 유병률 증가는 약시 시장의 성장을 가속하는 요인으로 작용하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장의 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·Covid와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 약시 시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
최종 용도 산업의 분석
세계의 약시 시장 : 성장률 분석
세계의 약시 시장 규모·성장률 : 실적(2019-2024년)
세계의 약시 시장 규모·성장률 : 예측(2024-2029년, 2034년)
세계의 약시 시장 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 약시 시장 : 질환 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
사시성 약시
굴절이상 약시
박탈성 약시
역약시
세계의 약시 시장 : 진단법별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
시력 검사
포토 스크리닝
브루크너 테스트
기타 진단법
세계의 약시 시장 : 치료법별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
안대
애트로핀 점안약
안경
TV 게임
기타 치료법
세계의 약시 시장 : 최종사용자별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 약시 시장 : 사시성 약시 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
선천성 사시성 약시
후천성 사시성 약시
비마비성 사시성 약시
마비성 사시성 약시
Misaligned Eyes의 치료(안대, 시력 교정)
세계의 약시 시장 : 굴절이상 약시 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
근시 굴절이상 약시
원시 굴절이상 약시
난시 굴절이상 약시
세계의 약시 시장 : 박탈성 약시 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
백내장에 의한 약시
안검 하수(눈꺼풀 처져)에 의한 약시
각막 혼탁에 의한 약시
외과적 개입 또는 패치에 의한 치료
세계의 약시 시장 : 역약시 유형별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
시신경 기능 장애에 의한 약시
부동시(부동 굴절이상)에 관련된 약시
시력 훈련 또는 광학 교정에 의한 치료
제7장 지역별·국가별 분석
세계의 약시 시장 : 지역별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
세계의 약시 시장 : 국가별, 실적·예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
약시 시장 : 경쟁 구도
약시 시장 : 기업 개요
Novartis AG(개요, 제품·서비스, 전략, 재무 분석)
Takeda Pharmaceutical Company Limited(개요, 제품·서비스, 전략, 재무 분석)
Biocon Limited(개요, 제품·서비스, 전략, 재무 분석)
Astellas Pharma Inc.(개요, 제품·서비스, 전략, 재무 분석)
Alcon Vision LLC(개요, 제품·서비스, 전략, 재무 분석)
제31장 기타 대기업과 혁신적 기업
Bausch Health Companies Inc.
HOYA Corp.
UnityPoint Health
Integra LifeSciences
Wockhardt Ltd.
Welch Allyn
Heidelberg Engineering Inc.
Orbis International
Oculus Optikgerate GmbH
Ocutrx Vision Technologies LLC
AccuVision
Vivid Vision Inc.
Fresnel Prism and Lens Co.
RevitalVision
WOW Vision Therapy
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력의 높은 국가·부문과 전략
약시 시장 : 최신 기회를 제공하는 국가(2029년)
약시 시장 : 최신 기회를 제공하는 부문(2029년)
약시 시장 : 성장 전략(2029년)
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSA
영문 목차
영문목차
Amblyopia, commonly referred to as lazy eye, is a condition affecting the development of vision where one eye does not achieve normal visual acuity, even with corrective eyewear such as glasses or contact lenses. Typically beginning in infancy or early childhood, amblyopia occurs due to a lack of proper coordination between the eye and the brain. As time progresses, the brain starts to favor the eye with better vision, leading to further deterioration of the weaker eye.
There are several types of amblyopia strabismus amblyopia, refractive amblyopia, deprivation amblyopia, and reverse amblyopia. Strabismus amblyopia results from misalignment of the eyes, causing a discrepancy in visual acuity between them. Diagnosis involves visual acuity tests, photo screening, Bruckner tests, and others. Treatment options include the use of eye patches, atropine drops, corrective glasses, and sometimes even therapeutic video games. Amblyopia affects diverse sectors including hospital pharmacies, retail pharmacies, and online pharmacies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The amblyopia market research report is one of a series of new reports from The Business Research Company that provides amblyopia market statistics, including amblyopia industry global market size, regional shares, competitors with a amblyopia market share, detailed amblyopia market segments, market trends and opportunities, and any further data you may need to thrive in the amblyopia industry. This amblyopia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The amblyopia market size has grown steadily in recent years. It will grow from $4.65 billion in 2024 to $4.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to a rise in the incidence of ophthalmological illnesses, rise in consumer demand for affordable glasses, the prevalence of hyperopia and myopia, an increased elderly population, and increased adoption of telemedicine.
The amblyopia market size is expected to see steady growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to the rise of digital health platforms, increasing availability of resources and support for parents, growing emphasis on preventive healthcare for children, increasing awareness about amblyopia, and the proliferation of specialized eye care centers and clinics. Major trends in the forecast period include technological advancements in diagnostics, the development of new treatment modalities, advances in the understanding of visual development, discoveries in neuroplasticity, and the development and approval of new drugs.
The forecast of 4.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of pediatric vision therapy devices and occlusion patches sourced from Germany and China, thereby reducing treatment effectiveness and elevating pediatric ophthalmology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of ophthalmological diseases is expected to drive growth in the amblyopia market moving forward. Ophthalmological diseases encompass a spectrum of disorders affecting the eyes, ranging from common ailments such as cataracts and glaucoma to rarer conditions such as retinitis pigmentosa and ocular tumors. Factors contributing to the rise in these diseases include increased screen time, aging populations, and environmental factors such as pollution. Amblyopia, in particular, can exacerbate ophthalmological conditions by causing the brain to disregard input from the weaker eye, potentially leading to permanent vision impairment and issues with depth perception if left untreated. According to the Centers for Disease Control and Prevention (CDC), over 3.4 million Americans aged 40 years and older were blind or visually impaired in January 2024, a number expected to double by 2030. Therefore, the escalating prevalence of ophthalmological diseases is a key driver behind the growth of the amblyopia market.
Leading companies in the amblyopia market are focusing on technological innovations like active peripheral stimulation (APS) to enhance peripheral vision therapy. APS is a therapeutic approach that stimulates peripheral nerves or tissues to activate sensory pathways, offering potential benefits for pain relief, rehabilitation, and neurological conditions. For example, in October 2024, AmblyoPlay, a US-based startup specializing in digital vision therapy, introduced APS to improve treatment for peripheral vision deficiencies. This cutting-edge technique targets conditions like amblyopia (lazy eye), strabismus, and convergence insufficiency, which impact spatial awareness and overall visual function. By stimulating peripheral vision, APS addresses a public health concern affecting up to 5% of the global population. AmblyoPlay has incorporated APS into a gamified platform, making vision therapy more engaging and enjoyable, especially for children, while promoting better adherence to treatment.
In October 2022, Sumitomo Corporation, a Japan-based electrical services company, partnered with Juntendo University to develop a virtual reality (VR) app for amblyopia treatment. This app aims to enhance treatment engagement and efficacy by making therapy more interactive and enjoyable for children. Juntendo University, a prominent private university in Japan, is collaborating to leverage VR technology in optimizing amblyopia treatment protocols.
Major companies operating in the amblyopia market are Novartis AG, Takeda Pharmaceutical Company Limited, Biocon Limited, Astellas Pharma Inc., Alcon Vision LLC, Bausch Health Companies Inc., HOYA Corp., UnityPoint Health, Integra LifeSciences, Wockhardt Ltd., Welch Allyn, Heidelberg Engineering Inc., Orbis International, Oculus Optikgerate GmbH, Ocutrx Vision Technologies LLC, AccuVision, Vivid Vision Inc., Fresnel Prism and Lens Co., RevitalVision, WOW Vision Therapy, Lancastle International Ltd., Novasight, Eyenovia Inc., Adaptica Srl, AmblyoPlay
North America was the largest region in the amblyopia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amblyopia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the amblyopia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The amblyopia market consists of revenues earned by entities by providing services such as screening and diagnosis, vision therapy, patching therapy, and orthoptic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The amblyopia market also includes sales of contact lenses, vision therapy software, lighting products, bangerter filters, and spectacle lenses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Amblyopia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on amblyopia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for amblyopia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The amblyopia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
2) By Refractive Amblyopia: Myopic Refractive Amblyopia; Hypermetropic Refractive Amblyopia; Astigmatic Refractive Amblyopia; Treatment Through Corrective Lenses (Glasses, Contact Lenses)
3) By Deprivation Amblyopia: Amblyopia Due To Cataracts; Amblyopia Caused By Ptosis (Drooping Eyelid); Amblyopia From Corneal Opacities; Treatment Through Surgical Interventions Or Patching
4) By Reverse Amblyopia: Amblyopia Due To Optic Nerve Dysfunction; Amblyopia Associated With Anisometropia (Unequal Refractive Errors); Treatment Through Vision Training Or Optical Correction
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Amblyopia Market Characteristics
3. Amblyopia Market Trends And Strategies
4. Amblyopia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Amblyopia Growth Analysis And Strategic Analysis Framework
5.1. Global Amblyopia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Amblyopia Market Growth Rate Analysis
5.4. Global Amblyopia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Amblyopia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Amblyopia Total Addressable Market (TAM)
6. Amblyopia Market Segmentation
6.1. Global Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Strabismus Amblyopia
Refractive Amblyopia
Deprivation Amblyopia
Reverse Amblyopia
6.2. Global Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Visual Acuity Tests
Photo Screening
Bruckner Test
Other Diagnosis
6.3. Global Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Eye Patches
Atropine Drops
Glasses
Video Games
Other Treatments
6.4. Global Amblyopia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Amblyopia Market, Sub-Segmentation Of Strabismus Amblyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Congenital Strabismus Amblyopia
Acquired Strabismus Amblyopia
Non-Paralytic Strabismus Amblyopia
Paralytic Strabismus Amblyopia
Treatment For Misaligned Eyes (Eye Patches, Vision Therapy)
6.6. Global Amblyopia Market, Sub-Segmentation Of Refractive Amblyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Myopic Refractive Amblyopia
Hypermetropic Refractive Amblyopia
Astigmatic Refractive Amblyopia
Treatment Through Corrective Lenses (Glasses, Contact Lenses)
6.7. Global Amblyopia Market, Sub-Segmentation Of Deprivation Amblyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amblyopia Due To Cataracts
Amblyopia Caused By Ptosis (Drooping Eyelid)
Amblyopia From Corneal Opacities
Treatment Through Surgical Interventions Or Patching
6.8. Global Amblyopia Market, Sub-Segmentation Of Reverse Amblyopia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amblyopia Due To Optic Nerve Dysfunction
Amblyopia Associated With Anisometropia (Unequal Refractive Errors)
Treatment Through Vision Training Or Optical Correction
7. Amblyopia Market Regional And Country Analysis
7.1. Global Amblyopia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Amblyopia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Amblyopia Market
8.1. Asia-Pacific Amblyopia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Amblyopia Market
9.1. China Amblyopia Market Overview
9.2. China Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Amblyopia Market
10.1. India Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Amblyopia Market
11.1. Japan Amblyopia Market Overview
11.2. Japan Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Amblyopia Market
12.1. Australia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Amblyopia Market
13.1. Indonesia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Amblyopia Market
14.1. South Korea Amblyopia Market Overview
14.2. South Korea Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Amblyopia Market
15.1. Western Europe Amblyopia Market Overview
15.2. Western Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Amblyopia Market
16.1. UK Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Amblyopia Market
17.1. Germany Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Amblyopia Market
18.1. France Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Amblyopia Market
19.1. Italy Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Amblyopia Market
20.1. Spain Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Amblyopia Market
21.1. Eastern Europe Amblyopia Market Overview
21.2. Eastern Europe Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Amblyopia Market
22.1. Russia Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Amblyopia Market
23.1. North America Amblyopia Market Overview
23.2. North America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Amblyopia Market
24.1. USA Amblyopia Market Overview
24.2. USA Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Amblyopia Market
25.1. Canada Amblyopia Market Overview
25.2. Canada Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Amblyopia Market
26.1. South America Amblyopia Market Overview
26.2. South America Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Amblyopia Market
27.1. Brazil Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Amblyopia Market
28.1. Middle East Amblyopia Market Overview
28.2. Middle East Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Amblyopia Market
29.1. Africa Amblyopia Market Overview
29.2. Africa Amblyopia Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Amblyopia Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Amblyopia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Amblyopia Market Competitive Landscape And Company Profiles
30.1. Amblyopia Market Competitive Landscape
30.2. Amblyopia Market Company Profiles
30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Biocon Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Alcon Vision LLC Overview, Products and Services, Strategy and Financial Analysis
31. Amblyopia Market Other Major And Innovative Companies
31.1. Bausch Health Companies Inc.
31.2. HOYA Corp.
31.3. UnityPoint Health
31.4. Integra LifeSciences
31.5. Wockhardt Ltd.
31.6. Welch Allyn
31.7. Heidelberg Engineering Inc.
31.8. Orbis International
31.9. Oculus Optikgerate GmbH
31.10. Ocutrx Vision Technologies LLC
31.11. AccuVision
31.12. Vivid Vision Inc.
31.13. Fresnel Prism and Lens Co.
31.14. RevitalVision
31.15. WOW Vision Therapy
32. Global Amblyopia Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Amblyopia Market
34. Recent Developments In The Amblyopia Market
35. Amblyopia Market High Potential Countries, Segments and Strategies
35.1 Amblyopia Market In 2029 - Countries Offering Most New Opportunities
35.2 Amblyopia Market In 2029 - Segments Offering Most New Opportunities
